Thalidomide-O-amido-PEG4-azide is a bifunctional PEG-based linker utilized in constructing PROTAC molecules. It enables the conjugation of a thalidomide-based E3 ligase ligand to a target protein binder, facilitating the study of targeted protein degradation in both cellular and biochemical assays.